Literature DB >> 11154995

Plasma homocysteine is not involved in the thrombotic risk of beta-thalassemia major patients.

B Barrano1, G Bertrand, T Isaja, R Curreri, S Musumeci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11154995     DOI： 10.1159/000039752

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  2 in total

1.  Prolidase activity and oxidative status in patients with thalassemia major.

Authors:  Alpay Cakmak; Murat Soker; Ahmet Koc; Nurten Aksoy
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

2.  Impact of Genetic Polymorphism of methylenetetrahydrofolate reductase C677T on Development of Hyperhomocysteinemia and Related Oxidative Changes in Egyptian β-Thalassemia Major Patients.

Authors:  Mai A Abd-Elmawla; Sherine M Rizk; Ilham Youssry; Amira A Shaheen
Journal:  PLoS One       Date:  2016-05-17       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.